Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate for acute Charcot neuroarthropathy in diabetic adults
ISRCTN86625608Phase 4Completed
- Sponsor
- Tameside and Glossop Integrated Care NHS Foundation Trust
- Start
- Feb 2008
- Modality
- Small Molecules
01
Overview
Phase 4, single-arm trial of alendronate in Charcot neuroarthropathy (CN), sponsored by Tameside and Glossop Integrated Care NHS Foundation Trust. Primary endpoint: Reduction in Charcot disease activity. Started Feb 2008; status: completed.
02
Drugs
alendronate
03
Conditions
Charcot neuroarthropathy (CN)
Beyond the preview
Go deeper on ISRCTN86625608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN86625608.